Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid Leukemia
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness and safety of Venetoclax in combination with standard
induction regimen for patients with acute leukemia and poor prognosis.